[{"Assets_0_Q1_USD":434390000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":14291000.0,"NetIncomeLossConverted_1_Q1_USD":440000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11823000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11747000.0,"StockholdersEquity_0_Q1_USD":199712000.0,"EarningsPerShareBasic_1_Q1_USD":0.04,"EarningsPerShareDiluted_1_Q1_USD":0.04,"RevenuesConverted_1_Q1_USD":52887000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]